Trial
NCT01542255
Metronomic Therapy in Patients With Metastatic Melanoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
—
Condition
Metastatic Melanoma
Intervention
vinblastine
Why stopped
Low accrual not allowing to support statistical endpoints
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-15